Loading
Referral Line 800-216-5556 | Text Size: View larger font-size View regular font-size

Clinical Trials at El Camino Hospital

Researcher with a patient

El Camino Hospital offers our patients the opportunity to participate in the latest research studies. We partner with pharmaceutical companies and device manufacturers, as well as major research organizations.

Learn more about:

  No Longer Enrolling Trials Enrolling Trials
Upcoming Trials
Cancer Center
NCT00601900
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer

Tissue Collection
MTGroup Biobank Tissue Study

Learn more


NCT00708019
Improving Cancer Pain Management Through Self-Care
Symptom Clusters in Oncology Patients Receiving Chemotherapy

Learn more



NCT00265850
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Case-Finding Trial
REACT Clinical Trial Lung Cancer Detection Study

Learn more


NCT00698815
Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer




NCT00874211
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases



Interventional Pulmonology
NCT01608490
RENEW (RePneu®) Evaluating a Treatment for Patients with Emphysema.

Learn more

 

Neuroscience Institute

 

NCT01141023
PPMI The Parkinson's Progression Markers Initiative (PPMI) is an observational research study to identify biomarkers of Parkinson's disease progression.

Learn more

 
Norma Melchor Heart & Vascular Institute   NCT01831895
CALM-FIM (Controlling and Lowering Blood Pressure with the MobiusHD™) Evaluates the safety and performance of the MobiusHD system in subjects with resistant hypertension.

Learn more

 
    NCT01531374
CoreValve is a Transcatheter Aortic Valve Implantation (TAVI) procedure, a minimally invasive treatment option for people with severe aortic stenosis. It is considered an investigational device, which means that clinical studies are required to determine if it is safe and effective treatment for aortic stenosis.

Learn more

 
    NCT02030418
The leadless pacemaker system (Nanostim™ LP) has been created to eliminate leads, pockets, and connectors required by conventional pacemakers and to eliminate associated complications. This concept could improve patient comfort by replacing a surgical procedure with a percutaneous one, eliminating the visible lump and scar at a conventional pacemaker's pectoral implant site and removing the need for activity restrictions to prevent dislodgement after implantation of a conventional lead.

Learn more

 
Orthopedic Institute XL TDR eXtreme Lateral Total Disc Replacement

Learn more